These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 31306192)

  • 41. Effect of prostate-specific membrane antigen positron emission tomography on the decision-making of radiation oncologists.
    Shakespeare TP
    Radiat Oncol; 2015 Nov; 10():233. PubMed ID: 26582424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Abdominal Splenosis Mimicking Peritoneal Metastasis in Prostate-Specific Membrane Antigen PET/CT, Confirmed With Selective Spleen SPECT/CT.
    Demirci E; Has Simsek D; Kabasakal L; Mülazimoğlu M
    Clin Nucl Med; 2017 Dec; 42(12):e504-e505. PubMed ID: 29076911
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PSMA PET/CT for staging and treatment of prostate cancer.
    Hofman M
    Clin Adv Hematol Oncol; 2019 Jul; 17(7):370-373. PubMed ID: 31449501
    [No Abstract]   [Full Text] [Related]  

  • 44. [The role of PSMA PET-CT in patients with metastatic prostate cancer].
    von Hardenberg J; Büsing KA; Nuhn P; Ritter M
    Urologe A; 2017 Nov; 56(11):1410-1416. PubMed ID: 28980045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gallium-68 Prostate-Specific Membrane Antigen PET Imaging.
    Hofman MS; Iravani A
    PET Clin; 2017 Apr; 12(2):219-234. PubMed ID: 28267455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography for Prostate Cancer: Distribution of Disease and Implications for Radiation Therapy Planning.
    Gupta SK; Watson T; Denham J; Shakespeare TP; Rutherford N; McLeod N; Picton K; Ainsworth P; Bonaventura T; Martin JM
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):701-709. PubMed ID: 29280465
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer.
    Jilg CA; Drendel V; Rischke HC; Beck T; Vach W; Schaal K; Wetterauer U; Schultze-Seemann W; Meyer PT
    Theranostics; 2017; 7(6):1770-1780. PubMed ID: 28529650
    [No Abstract]   [Full Text] [Related]  

  • 48. Incidental finding of ileal gastrointestinal stromal tumour during prostate cancer staging with prostate-specific membrane antigen scan.
    Lee DJW; Warner M; Shannon T; Moschilla J
    J Med Imaging Radiat Oncol; 2021 Feb; 65(1):89-91. PubMed ID: 33118296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. More than the prostate: Intrapancreatic accessory spleen and papillary thyroid cancer detected with
    Singh D; Horneman R; Nagra NK
    Hell J Nucl Med; 2018; 21(2):145-147. PubMed ID: 30006647
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effective Prostate-Specific Membrane Antigen-Based 18F-DCFPyL-Guided Cryoablation of a Single Positive Site in a Patient Believed to Be More Metastatic on 11C-Choline PET/CT.
    Cornelis FH; Durack JC; Morris MJ; Scher HI; Solomon SB
    Clin Nucl Med; 2017 Dec; 42(12):e516-e518. PubMed ID: 29099733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic Accuracy of
    Cantiello F; Gangemi V; Cascini GL; Calabria F; Moschini M; Ferro M; Musi G; Butticè S; Salonia A; Briganti A; Damiano R
    Urology; 2017 Aug; 106():139-145. PubMed ID: 28438628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current application and future perspectives of prostate specific membrane antigen PET imaging in prostate cancer.
    Ceci F; Castellucci P; Fanti S
    Q J Nucl Med Mol Imaging; 2019 Mar; 63(1):7-18. PubMed ID: 29521482
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostate-specific membrane antigen for prostate cancer theranostics: from imaging to targeted therapy.
    Arsenault F; Beauregard JM; Pouliot F
    Curr Opin Support Palliat Care; 2018 Sep; 12(3):359-365. PubMed ID: 29939893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective Comparison of 18F-Fluoromethylcholine Versus 68Ga-PSMA PET/CT in Prostate Cancer Patients Who Have Rising PSA After Curative Treatment and Are Being Considered for Targeted Therapy.
    Morigi JJ; Stricker PD; van Leeuwen PJ; Tang R; Ho B; Nguyen Q; Hruby G; Fogarty G; Jagavkar R; Kneebone A; Hickey A; Fanti S; Tarlinton L; Emmett L
    J Nucl Med; 2015 Aug; 56(8):1185-90. PubMed ID: 26112024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 68Ga-PSMA PET/CT False-Positive Tracer Uptake in Paget Disease.
    Sasikumar A; Joy A; Nanabala R; Pillai MR; T A H
    Clin Nucl Med; 2016 Oct; 41(10):e454-5. PubMed ID: 27556797
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of PSMA PET/CT imaging using a 68Ga-HBED-CC ligand in patients with prostate cancer and the value of early pelvic imaging.
    Kabasakal L; Demirci E; Ocak M; Akyel R; Nematyazar J; Aygun A; Halac M; Talat Z; Araman A
    Nucl Med Commun; 2015 Jun; 36(6):582-7. PubMed ID: 25738559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advances in Urologic Imaging: Prostate-Specific Membrane Antigen Ligand PET Imaging.
    Hofman MS; Iravani A; Nzenza T; Murphy DG
    Urol Clin North Am; 2018 Aug; 45(3):503-524. PubMed ID: 30031469
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison Between
    Cantiello F; Crocerossa F; Russo GI; Gangemi V; Ferro M; Vartolomei MD; Lucarelli G; Mirabelli M; Scafuro C; Ucciero G; De Cobelli O; Morgia G; Damiano R; Cascini GL
    Clin Genitourin Cancer; 2018 Oct; 16(5):385-391. PubMed ID: 29937067
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapy assessment in prostate cancer using choline and PSMA PET/CT.
    Ceci F; Herrmann K; Hadaschik B; Castellucci P; Fanti S
    Eur J Nucl Med Mol Imaging; 2017 Aug; 44(Suppl 1):78-83. PubMed ID: 28540419
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    Henkenberens C; VON Klot CA; Ross TL; Bengel FM; Wester HJ; Katja H; Christiansen H; Derlin T
    Anticancer Res; 2017 Mar; 37(3):1273-1279. PubMed ID: 28314292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.